Logo image of LO3.DE

LONZA GROUP AG-REG (LO3.DE) Stock Price, Quote, News and Overview

FRA:LO3 - Deutsche Boerse Ag - CH0013841017 - Common Stock - Currency: EUR

605.2  -17.2 (-2.76%)

LO3.DE Quote, Performance and Key Statistics

LONZA GROUP AG-REG

FRA:LO3 (7/24/2025, 7:00:00 PM)

605.2

-17.2 (-2.76%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap42.50B
Shares70.23M
Float68.60M
Yearly Dividend4.28
Dividend Yield0.7%
PE37.66
Fwd PE34.1
Earnings (Next)07-23 2025-07-23
IPO04-03 2002-04-03


LO3.DE short term performance overview.The bars show the price performance of LO3.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0.5 1 1.5

LO3.DE long term performance overview.The bars show the price performance of LO3.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of LO3.DE is 605.2 EUR. In the past month the price increased by 1.51%.

LONZA GROUP AG-REG / LO3 Daily stock chart

LO3.DE Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TN8.DE THERMO FISHER SCIENTIFIC INC 22.02 154.85B
DAP.DE DANAHER CORP 27.63 125.37B
1DHR.MI DANAHER CORP 25.95 117.73B
DIM.PA SARTORIUS STEDIM BIOTECH 42.37 17.03B
56S1.DE SARTORIUS STEDIM BIOTECH 45.72 16.91B
ILU.DE ILLUMINA INC 32.4 14.51B
SRT3.DE SARTORIUS AG-VORZUG 44.88 14.35B
ESF0.DE EUROFINS SCIENTIFIC 39.23 12.86B
ERF.PA EUROFINS SCIENTIFIC 20.84 12.53B
SRT.DE SARTORIUS AG 36.6 11.92B
QIA.DE QIAGEN N.V. 22.5 9.50B
1SXP.DE SCHOTT PHARMA AG& CO KGAA 26.58 3.92B

About LO3.DE

Company Profile

LO3 logo image Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. The company is headquartered in Basel, Basel-Stadt and currently employs 18,686 full-time employees. The company went IPO on 2002-04-03. The firm's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The firm divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.

Company Info

LONZA GROUP AG-REG

Muenchensteinerstrasse 38

Basel BASEL-STADT CH

Employees: 18686

LO3 Company Website

LO3 Investor Relations

Phone: 41613168111

LONZA GROUP AG-REG / LO3.DE FAQ

What is the stock price of LONZA GROUP AG-REG today?

The current stock price of LO3.DE is 605.2 EUR. The price decreased by -2.76% in the last trading session.


What is the ticker symbol for LONZA GROUP AG-REG stock?

The exchange symbol of LONZA GROUP AG-REG is LO3 and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is LO3.DE stock listed?

LO3.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for LONZA GROUP AG-REG stock?

31 analysts have analysed LO3.DE and the average price target is 713.2 EUR. This implies a price increase of 17.85% is expected in the next year compared to the current price of 605.2. Check the LONZA GROUP AG-REG stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is LONZA GROUP AG-REG worth?

LONZA GROUP AG-REG (LO3.DE) has a market capitalization of 42.50B EUR. This makes LO3.DE a Large Cap stock.


How many employees does LONZA GROUP AG-REG have?

LONZA GROUP AG-REG (LO3.DE) currently has 18686 employees.


What are the support and resistance levels for LONZA GROUP AG-REG (LO3.DE) stock?

LONZA GROUP AG-REG (LO3.DE) has a support level at 603.55 and a resistance level at 606.08. Check the full technical report for a detailed analysis of LO3.DE support and resistance levels.


Is LONZA GROUP AG-REG (LO3.DE) expected to grow?

The Revenue of LONZA GROUP AG-REG (LO3.DE) is expected to grow by 15.86% in the next year. Check the estimates tab for more information on the LO3.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy LONZA GROUP AG-REG (LO3.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LONZA GROUP AG-REG (LO3.DE) stock pay dividends?

LONZA GROUP AG-REG (LO3.DE) has a dividend yield of 0.7%. The yearly dividend amount is currently 4.28. Check the full fundamental report for a detailed analysis of LO3.DE dividend history, reliability and sustainability.


When does LONZA GROUP AG-REG (LO3.DE) report earnings?

LONZA GROUP AG-REG (LO3.DE) will report earnings on 2025-07-23.


What is the Price/Earnings (PE) ratio of LONZA GROUP AG-REG (LO3.DE)?

The PE ratio for LONZA GROUP AG-REG (LO3.DE) is 37.66. This is based on the reported non-GAAP earnings per share of 16.07 and the current share price of 605.2 EUR. Check the full fundamental report for a full analysis of the valuation metrics for LO3.DE.


LO3.DE Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to LO3.DE.


Chartmill TA Rating
Chartmill Setup Rating

LO3.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to LO3.DE. LO3.DE has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LO3.DE Financial Highlights

Over the last trailing twelve months LO3.DE reported a non-GAAP Earnings per Share(EPS) of 16.07. The EPS increased by 21.15% compared to the year before.


Industry RankSector Rank
PM (TTM) 8.56%
ROA 3.2%
ROE 6.13%
Debt/Equity 0.39
Chartmill High Growth Momentum
EPS Q2Q%27.43%
Sales Q2Q%-3.35%
EPS 1Y (TTM)21.15%
Revenue 1Y (TTM)-2.13%

LO3.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 81% to LO3.DE. The Buy consensus is the average rating of analysts ratings from 31 analysts.

For the next year, analysts expect an EPS growth of 10.44% and a revenue growth 15.86% for LO3.DE


Ownership
Inst Owners50.56%
Ins Owners0.05%
Short Float %N/A
Short RatioN/A
Analysts
Analysts81.29
Price Target713.2 (17.85%)
EPS Next Y10.44%
Revenue Next Year15.86%